Biomode

About:

Biomode is a provider of molecular diagnostics for the identification of pathogens in the food, environment, and life science industries.

Website: http://www.biomode-sa.com

Top Investors: EASME - EU Executive Agency for SMEs, Portugal Ventures, 2bpartner Sociedade de Capital de Risco S.A., Invicta Angels, ChangePartners

Description:

Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries. Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation) technology. Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens. Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials.

Total Funding Amount:

1.97M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Braga, Braga, Portugal

Founded Date:

2010-12-20

Contact Email:

info(AT)biomode-sa.com

Founders:

Carina Almeida, Laura Cerqueria, Nuno Azevedo

Number of Employees:

1-10

Last Funding Date:

2018-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai